Alessia Burocchi

639 total citations
16 papers, 498 citations indexed

About

Alessia Burocchi is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Alessia Burocchi has authored 16 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 4 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Alessia Burocchi's work include T-cell and B-cell Immunology (7 papers), Immune Cell Function and Interaction (7 papers) and Mast cells and histamine (4 papers). Alessia Burocchi is often cited by papers focused on T-cell and B-cell Immunology (7 papers), Immune Cell Function and Interaction (7 papers) and Mast cells and histamine (4 papers). Alessia Burocchi collaborates with scholars based in Italy, United States and France. Alessia Burocchi's co-authors include Mario P. Colombo, Claudio Tripodo, Silvia Piconese, Paola Pittoni, Andrea Gorzanelli, Sabina Sangaletti, Claudia Chiodoni, Laura Botti, Chiara Ratti and Caterina Vitali and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer Research.

In The Last Decade

Alessia Burocchi

16 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alessia Burocchi Italy 11 328 157 109 85 63 16 498
Ibrahim M. Sektioglu Germany 4 386 1.2× 305 1.9× 95 0.9× 76 0.9× 46 0.7× 4 587
Paola Pittoni Italy 12 571 1.7× 170 1.1× 125 1.1× 58 0.7× 37 0.6× 13 689
Gitte De Boeck Belgium 9 204 0.6× 159 1.0× 193 1.8× 80 0.9× 38 0.6× 9 548
Caterina Vitali Italy 8 489 1.5× 132 0.8× 205 1.9× 106 1.2× 53 0.8× 9 705
Victoria Saferding Austria 10 186 0.6× 93 0.6× 248 2.3× 55 0.6× 92 1.5× 24 451
Cyril Šálek Czechia 14 311 0.9× 275 1.8× 243 2.2× 37 0.4× 74 1.2× 47 728
Dávid Győri Hungary 11 228 0.7× 227 1.4× 244 2.2× 46 0.5× 61 1.0× 16 526
Thomas Magg Germany 12 277 0.8× 111 0.7× 162 1.5× 35 0.4× 62 1.0× 25 485
Xianfeng Fang China 12 287 0.9× 176 1.1× 211 1.9× 16 0.2× 71 1.1× 19 535
Shigeaki Umeda Japan 13 173 0.5× 187 1.2× 215 2.0× 35 0.4× 119 1.9× 41 557

Countries citing papers authored by Alessia Burocchi

Since Specialization
Citations

This map shows the geographic impact of Alessia Burocchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessia Burocchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessia Burocchi more than expected).

Fields of papers citing papers by Alessia Burocchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessia Burocchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessia Burocchi. The network helps show where Alessia Burocchi may publish in the future.

Co-authorship network of co-authors of Alessia Burocchi

This figure shows the co-authorship network connecting the top 25 collaborators of Alessia Burocchi. A scholar is included among the top collaborators of Alessia Burocchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessia Burocchi. Alessia Burocchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Orsini, Paolo, Simona Rizzi, Ulisse Cucchi, et al.. (2024). Abstract 5805: A novel platform of diversified payloads to drive ADC innovation. Cancer Research. 84(6_Supplement). 5805–5805. 1 indexed citations
2.
Cervi, Giovanni, Roberto D’Alessio, Simona Bindi, et al.. (2024). Discovery and optimization of 4-pyrazolyl-2-aminopyrimidine derivatives as potent spleen tyrosine kinase (SYK) inhibitors. European Journal of Medicinal Chemistry. 270. 116375–116375. 2 indexed citations
3.
Nanni, Patrizia, Carla De Giovanni, Alessia Burocchi, et al.. (2018). OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis. OncoImmunology. 7(8). e1465164–e1465164. 4 indexed citations
4.
Ratti, Chiara, Laura Botti, Valeria Cancila, et al.. (2017). Trabectedin Overrides Osteosarcoma Differentiative Block and Reprograms the Tumor Immune Environment Enabling Effective Combination with Immune Checkpoint Inhibitors. Clinical Cancer Research. 23(17). 5149–5161. 64 indexed citations
5.
Tripodo, Claudio, Alessia Burocchi, Pier Paolo Piccaluga, et al.. (2017). Persistent Immune Stimulation Exacerbates Genetically Driven Myeloproliferative Disorders via Stromal Remodeling. Cancer Research. 77(13). 3685–3699. 28 indexed citations
6.
Mion, Francesca, Stefania Vetrano, Silvia Tonon, et al.. (2017). Reciprocal influence of B cells and tumor macro and microenvironments in theApcMin/+model of colorectal cancer. OncoImmunology. 6(8). e1336593–e1336593. 8 indexed citations
7.
Rigoni, Alice, Lucia Bongiovanni, Alessia Burocchi, et al.. (2015). Mast Cells Infiltrating Inflamed or Transformed Gut Alternatively Sustain Mucosal Healing or Tumor Growth. Cancer Research. 75(18). 3760–3770. 25 indexed citations
8.
Burocchi, Alessia, Paola Pittoni, Esmerina Tili, et al.. (2015). Regulated Expression of miR-155 is Required for iNKT Cell Development. Frontiers in Immunology. 6. 140–140. 22 indexed citations
9.
Zappasodi, Roberta, Alessia Burocchi, Anna Rossini, et al.. (2015). OX40 expression in tumor-associated Tregs as a potential prognostic biomarker and immunotherapeutic target in ovarian cancer.. Journal of Clinical Oncology. 33(15_suppl). e16576–e16576. 1 indexed citations
10.
Sangaletti, Sabina, Claudio Tripodo, Caterina Vitali, et al.. (2014). Osteopontin Shapes Immunosuppression in the Metastatic Niche. Cancer Research. 74(17). 4706–4719. 117 indexed citations
11.
Mion, Francesca, Luca Danelli, Barbara Toffoletto, et al.. (2014). Mast Cells Control the Expansion and Differentiation of IL-10–Competent B Cells. The Journal of Immunology. 193(9). 4568–4579. 32 indexed citations
12.
Burocchi, Alessia, Mario P. Colombo, & Silvia Piconese. (2013). Convergences and Divergences of Thymus- and Peripherally Derived Regulatory T Cells in Cancer. Frontiers in Immunology. 4. 247–247. 22 indexed citations
13.
Piconese, Silvia, Massimo Costanza, Claudio Tripodo, et al.. (2011). The matricellular protein SPARC supports follicular dendritic cell networking toward Th17 responses. Journal of Autoimmunity. 37(4). 300–310. 26 indexed citations
14.
Piconese, Silvia, Massimo Costanza, Silvia Musio, et al.. (2011). Exacerbated experimental autoimmune encephalomyelitis in mast-cell-deficient KitW-sh/W-sh mice. Laboratory Investigation. 91(4). 627–641. 53 indexed citations
15.
Burocchi, Alessia, Paola Pittoni, Andrea Gorzanelli, Mario P. Colombo, & Silvia Piconese. (2011). Intratumor OX40 stimulation inhibits IRF1 expression and IL‐10 production by Treg cells while enhancing CD40L expression by effector memory T cells. European Journal of Immunology. 41(12). 3615–3626. 39 indexed citations
16.
Piconese, Silvia, Paola Pittoni, Alessia Burocchi, et al.. (2010). A non‐redundant role for OX40 in the competitive fitness of Treg in response to IL‐2. European Journal of Immunology. 40(10). 2902–2913. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026